BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2678 related articles for article (PubMed ID: 23543569)

  • 21. Drugs to reduce bleeding and transfusion in major open vascular or endovascular surgery: a systematic review and network meta-analysis.
    Beverly A; Ong G; Kimber C; Sandercock J; Dorée C; Welton NJ; Wicks P; Estcourt LJ
    Cochrane Database Syst Rev; 2023 Feb; 2(2):CD013649. PubMed ID: 36800489
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thromboelastography (TEG) or thromboelastometry (ROTEM) to monitor haemostatic treatment versus usual care in adults or children with bleeding.
    Wikkelsø A; Wetterslev J; Møller AM; Afshari A
    Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD007871. PubMed ID: 27552162
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thrombopoietin mimetics for patients with myelodysplastic syndromes.
    Dodillet H; Kreuzer KA; Monsef I; Skoetz N
    Cochrane Database Syst Rev; 2017 Sep; 9(9):CD009883. PubMed ID: 28962071
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Restrictive versus liberal red blood cell transfusion strategies for people with haematological malignancies treated with intensive chemotherapy or radiotherapy, or both, with or without haematopoietic stem cell support.
    Estcourt LJ; Malouf R; Trivella M; Fergusson DA; Hopewell S; Murphy MF
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD011305. PubMed ID: 28128441
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preoperative blood transfusions for sickle cell disease.
    Estcourt LJ; Kimber C; Trivella M; Doree C; Hopewell S
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD003149. PubMed ID: 32614473
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pro-coagulant haemostatic factors for the prevention and treatment of bleeding in people without haemophilia.
    Fabes J; Brunskill SJ; Curry N; Doree C; Stanworth SJ
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD010649. PubMed ID: 30582172
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Single-donor (apheresis) platelets and pooled whole-blood-derived platelets--significance and assessment of both blood products].
    Hitzler WE
    Clin Lab; 2014; 60(4):S1-39. PubMed ID: 24779310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stem cell therapy for chronic ischaemic heart disease and congestive heart failure.
    Fisher SA; Brunskill SJ; Doree C; Mathur A; Taggart DP; Martin-Rendon E
    Cochrane Database Syst Rev; 2014 Apr; (4):CD007888. PubMed ID: 24777540
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early versus late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.
    Aher SM; Ohlsson A
    Cochrane Database Syst Rev; 2006 Jul; (3):CD004865. PubMed ID: 16856063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Granulocyte transfusions for neonates with confirmed or suspected sepsis and neutropaenia.
    Mohan P; Brocklehurst P
    Cochrane Database Syst Rev; 2003; (4):CD003956. PubMed ID: 14584000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transfusion of red blood cells stored for shorter versus longer duration for all conditions.
    Shah A; Brunskill SJ; Desborough MJ; Doree C; Trivella M; Stanworth SJ
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD010801. PubMed ID: 30578732
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coblation versus other surgical techniques for tonsillectomy.
    Pynnonen M; Brinkmeier JV; Thorne MC; Chong LY; Burton MJ
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD004619. PubMed ID: 28828761
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thrombopoietin receptor agonists for prevention and treatment of chemotherapy-induced thrombocytopenia in patients with solid tumours.
    Zhang X; Chuai Y; Nie W; Wang A; Dai G
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD012035. PubMed ID: 29178132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Granulocyte transfusions for treating infections in people with neutropenia or neutrophil dysfunction.
    Estcourt LJ; Stanworth SJ; Hopewell S; Doree C; Trivella M; Massey E
    Cochrane Database Syst Rev; 2016 Apr; 4(4):CD005339. PubMed ID: 27128488
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interventions for preventing silent cerebral infarcts in people with sickle cell disease.
    Estcourt LJ; Fortin PM; Hopewell S; Trivella M; Doree C; Abboud MR
    Cochrane Database Syst Rev; 2017 May; 5(5):CD012389. PubMed ID: 28500860
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nutritional support for liver disease.
    Koretz RL; Avenell A; Lipman TO
    Cochrane Database Syst Rev; 2012 May; 2012(5):CD008344. PubMed ID: 22592729
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia.
    Simpson E; Lin Y; Stanworth S; Birchall J; Doree C; Hyde C
    Cochrane Database Syst Rev; 2012 Mar; (3):CD005011. PubMed ID: 22419303
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prothrombin complex concentrate for reversal of vitamin K antagonist treatment in bleeding and non-bleeding patients.
    Johansen M; Wikkelsø A; Lunde J; Wetterslev J; Afshari A
    Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD010555. PubMed ID: 26151108
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interventions for preventing silent cerebral infarcts in people with sickle cell disease.
    Estcourt LJ; Kimber C; Hopewell S; Trivella M; Doree C; Abboud MR
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD012389. PubMed ID: 32250453
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preoperative blood transfusions for sickle cell disease.
    Estcourt LJ; Fortin PM; Trivella M; Hopewell S
    Cochrane Database Syst Rev; 2016 Apr; 4(4):CD003149. PubMed ID: 27049331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 134.